Modulation of Benzo[a]pyrene induced immunotoxicity in mice actively immunized with a B[a]P-diphtheria toxoid conjugate

Toxicology and Applied Pharmacology

Volumn 240, Issue 1, 2009, Pages 37-45

  Schellenberger, Mario T ^a   Grova, Nathalie ^a   Willième, Stéphanie ^a   Farinelle, Sophie ^a   Prodhomme, Emmanuel J F ^a   Muller, Claude P ^a  

^a LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

B cells; Balb c; Benzo a pyrene; Cyp1a1; Cyp1b1; Immunotoxicity; T cells

Indexed keywords

ANTIBODY; BENZO[A]PYRENE; BENZO[A]PYRENE DIPHTHERIA TOXOID CONJUGATE VACCINE; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; GAMMA INTERFERON; GLUTATHIONE TRANSFERASE; INTERLEUKIN 12; POLYCYCLIC AROMATIC HYDROCARBON; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA ADDUCT; ENZYME INDUCTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNIZATION; IMMUNOMODULATION; IMMUNOTOXICITY; LIVER MICROSOME; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; METABOLITE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; RISK FACTOR; SPLEEN CELL; T LYMPHOCYTE; VACCINATION;

MAMMALIA; MUS;

EID: 69749090708     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.06.019     Document Type: Article

References (67)

1. Andrieux L., Langouet S., Fautrel A., Ezan F., Krauser J.A., Savouret J.F., Guengerich F.P., Baffet G., and Guillouzo A. Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes. Mol. Pharmacol. 65 (2004) 934-943
2. Arlt V.M., Stiborova M., Henderson C.J., Thiemann M., Frei E., Aimova D., Singh R., Gamboa da Costa G., Schmitz O.J., Farmer P.B., Wolf C.R., and Phillips D.H. Metabolic activation of benzo[a]pyrene in vitro by hepatic cytochrome P450 contrasts with detoxification in vivo: experiments with hepatic cytochrome P450 reductase null mice. Carcinogenesis 29 (2008) 656-665
3. Baird W.M., Hooven L.A., and Mahadevan B. Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ. Mol. Mutagen. 45 (2005) 106-114
4. Baron J.M., Zwadlo-Klarwasser G., Jugert F., Hamann W., Rubben A., Mukhtar H., and Merk H.F. Cytochrome P450 1B1: a major P450 isoenzyme in human blood monocytes and macrophage subsets. Biochem. Pharmacol. 56 (1998) 1105-1110
5. Burchiel S.W., and Luster M.I. Signaling by environmental polycyclic aromatic hydrocarbons in human lymphocytes. Clin. Immunol. 98 (2001) 2-10
6. Burchiel S.W., Knall C.M., Davis II J.W., Paules R.S., Boggs S.E., and Afshari C.A. Analysis of genetic and epigenetic mechanisms of toxicity: potential roles of toxicogenomics and proteomics in toxicology. Toxicol. Sci. 59 (2001) 193-195
7. Buters J.T., Sakai S., Richter T., Pineau T., Alexander D.L., Savas U., Doehmer J., Ward J.M., Jefcoate C.R., and Gonzalez F.J. Cytochrome P450 CYP1B1 determines susceptibility to 7, 12-dimethylbenz[a]anthracene-induced lymphomas. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 1977-1982
8. Carlson E.A., Li Y., and Zelikoff J.T. Suppressive effects of benzo[a]pyrene upon fish immune function: evolutionarily conserved cellular mechanisms of immunotoxicity. Mar. Environ. Res. 58 (2004) 731-734
9. Choudhary D., Jansson I., Stoilov I., Sarfarazi M., and Schenkman J.B. Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. Arch. Biochem. Biophys. 436 (2005) 50-61
10. Davila D.R., Romero D.L., and Burchiel S.W. Human T cells are highly sensitive to suppression of mitogenesis by polycyclic aromatic hydrocarbons and this effect is differentially reversed by alpha-naphthoflavone. Toxicol. Appl. Pharmacol. 139 (1996) 333-341
11. De Buck S.S., Bouche F.B., Brandenburger A., and Muller C.P. Modulation of the metabolism and adverse effects of benzo[a]pyrene by a specific antibody: a novel host factor in environmental carcinogenesis?. Carcinogenesis 26 (2005) 835-844
12. Galvan N., Jaskula-Sztul R., MacWilliams P.S., Czuprynski C.J., and Jefcoate C.R. Bone marrow cytotoxicity of benzo[a]pyrene is dependent on CYP1B1 but is diminished by Ah receptor-mediated induction of CYP1A1 in liver. Toxicol. Appl. Pharmacol. 193 (2003) 84-96
13. Galvan N., Teske D.E., Zhou G., Moorthy B., MacWilliams P.S., Czuprynski C.J., and Jefcoate C.R. Induction of CYP1A1 and CYP1B1 in liver and lung by benzo(a)pyrene and 7,12-d imethylbenz(a)anthracene do not affect distribution of polycyclic hydrocarbons to target tissue: role of AhR and CYP1B1 in bone marrow cytotoxicity. Toxicol. Appl. Pharmacol. 202 (2005) 244-257
14. Gelboin H.V. Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. Physiol. Rev. 60 (1980) 1107-1166
15. Grabarek Z., and Gergely J. Zero-length crosslinking procedure with the use of active esters. Anal. Biochem. 185 (1990) 131-135
16. Grova N., Schroeder H., Farinelle S., Prodhomme E., Valley A., and Muller C.P. Sub-acute administration of benzo[a]pyrene (B[a]P) reduces anxiety-related behaviour in adult mice and modulates regional expression of N-methyl-d-aspartate (NMDA) receptors genes in relevant brain regions. Chemosphere 73 (2008) S295-302
17. Grova N., Prodhomme E.J., Schellenberger M.T., Farinelle S., and Muller C.P. Modulation of carcinogen bioavailability by immunisation with benzo[a]pyrene-conjugate vaccines. Vaccine 27 (2009) 4142-4151
18. Hanaoka T., Yamano Y., Pan G., Hara K., Ichiba M., Zhang J., Zhang S., Liu T., Li L., Takahashi K., Kagawa J., and Tsugane S. Cytochrome P450 1B1 mRNA levels in peripheral blood cells and exposure to polycyclic aromatic hydrocarbons in Chinese coke oven workers. Sci. Total. Environ. 296 (2002) 27-33
19. Hardin J.A., Hinoshita F., and Sherr D.H. Mechanisms by which benzo[a]pyrene, an environmental carcinogen, suppresses B cell lymphopoiesis. Toxicol. Appl. Pharmacol. 117 (1992) 155-164
20. Harlow E., and Lane D. Antibodies: a Laboratory Manual (1988), Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (USA
21. Hasman A., and Holm S. Nicotine conjugate vaccine: is there a right to a smoking future?. J. Med. Ethics. 30 (2004) 344-345
22. Hattemer-Frey H.A., and Travis C.C. Benzo-a-pyrene: environmental partitioning and human exposure. Toxicol. Ind. Health 7 (1991) 141-157
23. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 91 (1999) 1194-1210
24. Heidel S.M., Czuprynski C.J., and Jefcoate C.R. Bone marrow stromal cells constitutively express high levels of cytochrome P4501B1 that metabolize 7,12-dimethylbenz[a]anthracene. Mol. Pharmacol. 54 (1998) 1000-1006
25. Hieda Y., Keyler D.E., VanDeVoort J.T., Niedbala R.S., Raphael D.E., Ross C.A., and Pentel P.R. Immunization of rats reduces nicotine distribution to brain. Psychopharmacology (Berl) 143 (1999) 150-157
26. Hieda Y., Keyler D.E., Ennifar S., Fattom A., and Pentel P.R. Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain. Int. J. Immunopharmacol. 22 (2000) 809-819
27. Janoff E.N., Hardy W.D., Smith P.D., and Wahl S.M. Humoral recall responses in HIV infection. Levels, specificity, and affinity of antigen-specific IgG. J. Immunol. 147 (1991) 2130-2135
28. Jerina D.M., Sayer J.M., Yagi H., Croisy-Delcey M., Ittah Y., Thakker D.R., Wood A.W., Chang R.L., Levin W., and Conney A.H. Highly tumorigenic bay-region diol epoxides from the weak carcinogen benzo[c]phenanthrene. Adv. Exp. Med. Biol. 136 Pt. A (1981) 501-523
29. John K., Ragavan N., Pratt M.M., Singh P.B., Al-Buheissi S., Matanhelia S.S., Phillips D.H., Poirier M.C., and Martin F.L. Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate. Prostate 69 (2009) 505-519
30. Junghans R.P. IgG biosynthesis: no "immunoregulatory feedback". Blood 90 (1997) 3815-3818
31. Kawabata T.T., and White Jr. K.L. Suppression of the vitro humoral immune response of mouse splenocytes by benzo(a)pyrene metabolites and inhibition of benzo(a)pyrene-induced immunosuppression by alpha-naphthoflavone. Cancer Res. 47 (1987) 2317-2322
32. Kawabata T.T., and White Jr. K.L. Benzo(a)pyrene metabolism by murine spleen microsomes. Cancer Res. 49 (1989) 5816-5822
33. Ladics G.S., Kawabata T.T., Munson A.E., and White Jr. K.L. Metabolism of benzo[a]pyrene by murine splenic cell types. Toxicol. Appl. Pharmacol. 116 (1992) 248-257
34. Lambré, C., and Muller, C., (2004). Collection of occurrence data on polycyclic aromatic hydrocabons in food. Directorate-General Health and Consumer Protection.
35. LeSage M.G., Keyler D.E., Hieda Y., Collins G., Burroughs D., Le C., and Pentel P.R. Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats. Psychopharmacology (Berl). 184 (2006) 409-416
36. Lewtas J., Walsh D., Williams R., and Dobias L. Air pollution exposure-DNA adduct dosimetry in humans and rodents: evidence for non-linearity at high doses. Mutat. Res. 378 (1997) 51-63
37. Liang H.C., McKinnon R.A., and Nebert D.W. Sensitivity of CYP1A1 mRNA inducibility by dioxin is the same in Cyp1a2(+/+) wild-type and Cyp1a2(-/-) null mutant mice. Biochem. Pharmacol. 54 (1997) 1127-1131
38. Martell B.A., Mitchell E., Poling J., Gonsai K., and Kosten T.R. Vaccine pharmacotherapy for the treatment of cocaine dependence. Biol. Psychiatry 58 (2005) 158-164
39. Mihaltan F. The vaccine against nicotine-the future for smoking cessation?. Pneumologia 56 (2007) 101-103
40. Moolten F., Capparell N., and Boger E. Reduction of respiratory tract binding of benzo[a]pyrene in mice by immunization. J. Natl. Cancer Inst. 61 (1978) 1347-1349
41. Moolten F.L., Capparell N.J., Boger E., and Mahathalang P. Induction of antibodies against carcinogenic polycyclic aromatic hydrocarbons. Nature 272 (1978) 614-616
42. Mudzinski S.P. Effects of benzo[a]pyrene on concanavalin A-stimulated human peripheral blood mononuclear cells in vitro: inhibition of proliferation but no effect on parameters related to the G1 phase of the cell cycle. Toxicol. Appl. Pharmacol. 119 (1993) 166-174
43. Peck R.M., and Peck E.B. Inhibition of chemically induced neoplasia by immunization with antigenic carcinogen-protein conjugate. Cancer Res. 31 (1971) 1550-1554
44. Pentel P.R., Malin D.H., Ennifar S., Hieda Y., Keyler D.E., Lake J.R., Milstein J.R., Basham L.E., Coy R.T., Moon J.W., Naso R., and Fattom A. A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats. Pharmacol. Biochem. Behav. 65 (2000) 191-198
45. Perera F.P., Hemminki K., Young T.L., Brenner D., Kelly G., and Santella R.M. Detection of polycyclic aromatic hydrocarbon-DNA adducts in white blood cells of foundry workers. Cancer Res. 48 (1988) 2288-2291
46. Peter Guengerich F., Chun Y.J., Kim D., Gillam E.M., and Shimada T. Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies. Mutat. Res. 523-524 (2003) 173-182
47. Phillips D.H. Polycyclic aromatic hydrocarbons in the diet. Mutat. Res. 443 (1999) 139-147
48. Podechard N., Lecureur V., Le Ferrec E., Guenon I., Sparfel L., Gilot D., Gordon J.R., Lagente V., and Fardel O. Interleukin-8 induction by the environmental contaminant benzo(a)pyrene is aryl hydrocarbon receptor-dependent and leads to lung inflammation. Toxicol. Lett. 177 (2008) 130-137
49. Poirier M.C. Chemical-induced DNA damage and human cancer risk. Nat. Rev. Cancer 4 (2004) 630-637
50. Pushparajah D.S., Umachandran M., Plant K.E., Plant N., and Ioannides C. Up-regulation of the glutathione S-transferase system in human liver by polycyclic aromatic hydrocarbons; comparison with rat liver and lung. Mutagenesis 23 (2008) 299-308
51. Rahman A., Barrowman J.A., and Rahimtula A. The influence of bile on the bioavailability of polynuclear aromatic hydrocarbons from the rat intestine. Can. J. Physiol. Pharmacol. 64 (1986) 1214-1218
52. Romero D.L., Mounho B.J., Lauer F.T., Born J.L., and Burchiel S.W. Depletion of glutathione by benzo(a)pyrene metabolites, ionomycin, thapsigargin, and phorbol myristate in human peripheral blood mononuclear cells. Toxicol. Appl. Pharmacol. 144 (1997) 62-69
53. Sagiv S.K., Gaudet M.M., Eng S.M., Abrahamson P.E., Shantakumar S., Teitelbaum S.L., Bell P., Thomas J.A., Neugut A.I., Santella R.M., and Gammon M.D. Polycyclic aromatic hydrocarbon-DNA adducts and survival among women with breast cancer. Environ. Res. 109 (2009) 287-291
54. Salas V.M., and Burchiel S.W. Apoptosis in Daudi human B cells in response to benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol. Toxicol. Appl. Pharmacol. 151 (1998) 367-376
55. Santella R.M., Hsieh L.L., Lin C.D., Viet S., and Weinstein I.B. Quantitation of exposure to benzo[a]pyrene with monoclonal antibodies. Environ. Health Perspect. 62 (1985) 95-99
56. Schote A.B., Turner J.D., Schiltz J., and Muller C.P. Nuclear receptors in human immune cells: expression and correlations. Mol. Immunol. 44 (2007) 1436-1445
57. Schreck I., Chudziak D., Schneider S., Seidel A., Platt K.L., Oesch F., and Weiss C. Influence of aryl hydrocarbon- (Ah) receptor and genotoxins on DNA repair gene expression and cell survival of mouse hepatoma cells. Toxicology 259 (2009) 91-96
58. Shimada T., Sugie A., Yamada T., Kawazoe H., Hashimoto M., Azuma E., Nakajima T., Inoue K., and Oda Y. Dose-response studies on the induction of liver cytochromes P4501A1 and 1B1 by polycyclic aromatic hydrocarbons in arylhydrocarbon-responsive C57BL/6J mice. Xenobiotica 33 (2003) 957-971
59. Silbart L.K., and Keren D.F. Reduction of intestinal carcinogen absorption by carcinogen-specific secretory immunity. Science 243 (1989) 1462-1464
60. Thyssen J., Althoff J., Kimmerle G., and Mohr U. Inhalation studies with benzo[a]pyrene in Syrian golden hamsters. J. Natl. Cancer Inst. 66 (1981) 575-577
61. van Schooten F.J., Moonen E.J., van der Wal L., Levels P., and Kleinjans J.C. Determination of polycyclic aromatic hydrocarbons (PAH) and their metabolites in blood, feces, and urine of rats orally exposed to PAH contaminated soils. Arch. Environ. Contam. Toxicol. 33 (1997) 317-322
62. Wagena E.J., de Vos A., Horwith G., and van Schayck C.P. The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: results of a randomized, placebo-controlled phase 1/2 trial. Nicotine Tob. Res. 10 (2008) 213-218
63. Wislocki P.G., Wood A.W., Chang R.L., Levin W., Yagi H., Hernandez O., Jerina D.M., and Conney A.H. High mutagenicity and toxicity of a diol epoxide derived from benzo(a)pyrene. Biochem. Biophys. Res. Commun. 68 (1976) 1006-1012
64. Wolterbeek A.P., Schoevers E.J., Rutten A.A., and Feron V.J. A critical appraisal of intratracheal instillation of benzo[a]pyrene to Syrian golden hamsters as a model in respiratory tract carcinogenesis. Cancer Lett. 89 (1995) 107-116
65. Yamazaki H., Terada M., Tsuboi A., Matsubara C., Hata T., and Kakiuchi Y. Distribution and binding pattern of benzo(a)pyrene in rat liver, lung and kidney constituents after oral administration. Toxicol. Environ. Chem. 15 (1987) 71-81
66. Yuan J.W., Krieger J.A., Maples K.R., Born J.L., and Burchiel S.W. Polycyclic aromatic hydrocarbons decrease intracellular glutathione levels in the A20.1 murine B cell lymphoma. Fundam. Appl. Toxicol. 23 (1994) 336-341
67. Zhang Y.J., Weksler B.B., Wang L., Schwartz J., and Santella R.M. Immunohistochemical detection of polycyclic aromatic hydrocarbon-DNA damage in human blood vessels of smokers and non-smokers. Atherosclerosis 140 (1998) 325-331